Author:
Schlegelberger Brigitte,Lipp Martin
Publisher
Springer Berlin Heidelberg
Reference148 articles.
1. Achten R, Verhoef G, Vanuytsel L et al. (2002) T-cell/histiocyte-rich large B-cell lymphoma: a distinct clinicopathologic entity. J Clin Oncol 20:1269–1277
2. Adams JM, Harris AW, Pinkert CA et al. (1985) The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318: 533–538
3. Adida C, Haioun C, Gaulard P et al. (2000) Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood 96:1921–1925
4. Aguiar RC, Yakushijin Y, Kharbanda S et al. (2000) BAL is a novel risk-related gene in diffuse large B-cell lymphomas that enhances cellular migration. Blood 96:4328–4334
5. Akao Y, Seto M, Yamamoto K et al. (1992) The RCK gene associated with t(11;14) translocation is distinct from the MLL/ALL-1 gene with t(4;11) and t(11;19) translocations. Cancer Res 52:6083–6087